These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 511604

  • 1. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
    Coombes RC, Powles TJ, Gehrke CW, Waalkes TP, Neville AM.
    Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
    [Abstract] [Full Text] [Related]

  • 2. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA, Grever MR, Speicher CE, Trewyn RW.
    J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
    [Abstract] [Full Text] [Related]

  • 3. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI, McClure TD, el-Shakawi S, Fielding A, Schram KH, Newton RP.
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [Abstract] [Full Text] [Related]

  • 4. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
    Tormey DC, Waalkes TP, Gehrke CW.
    J Surg Oncol; 1980 Jun; 14(3):267-73. PubMed ID: 7392649
    [Abstract] [Full Text] [Related]

  • 5. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
    Woo KB, Waalkes TP, Ahmann DL, Tormey DC, Gehrke CW, Oliverio VT.
    Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
    [Abstract] [Full Text] [Related]

  • 6. Biochemically detectable tumor markers in urine of bladder cancer patients.
    Irving CC.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2872-4. PubMed ID: 872116
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine.
    Waalkes TP, Dinsmore SR, Mrochek JE.
    J Natl Cancer Inst; 1973 Jul; 51(1):271-4. PubMed ID: 4720877
    [No Abstract] [Full Text] [Related]

  • 10. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
    Koshida K, Harmenberg J, Stendahl U, Wahren B, Borgström E, Helström L, Andersson L.
    Urol Res; 1985 Jul; 13(5):213-8. PubMed ID: 4060364
    [Abstract] [Full Text] [Related]

  • 11. Differential excretion of modified nucleosides in adult acute leukemia.
    Heldman DA, Grever MR, Trewyn RW.
    Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
    [Abstract] [Full Text] [Related]

  • 12. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process.
    Tebib JG, Reynaud C, Cedoz JP, Letroublon MC, Niveleau A.
    Br J Rheumatol; 1997 Sep; 36(9):990-5. PubMed ID: 9376997
    [Abstract] [Full Text] [Related]

  • 13. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
    Nyholm KK, Sjolin KE, Wolf H, Hammer M, Knudsen J, Stahl D, Nielsen HR.
    Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
    Zheng YF, Kong HW, Xiong JH, Lv S, Xu GW.
    Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
    [Abstract] [Full Text] [Related]

  • 15. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM, Di Stefano C, Wixforth A, Schmid HR.
    J Chromatogr A; 1997 Feb 28; 763(1-2):193-7. PubMed ID: 9129323
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
    Cho SH, Choi MH, Lee WY, Chung BC.
    Clin Biochem; 2009 Apr 28; 42(6):540-3. PubMed ID: 19186175
    [Abstract] [Full Text] [Related]

  • 17. [Excretion of methylated nucleosides in the initial therapy phase in a case of anorexia nervosa].
    Clemens P, Schöch G, Ziemer G, Altenhoff J, Erb N, Lorenz H, Müller J, Grüttner R.
    Padiatr Padol; 1982 Apr 28; 17(2):157-63. PubMed ID: 7099674
    [Abstract] [Full Text] [Related]

  • 18. High-performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids.
    Davis GE, Suits RD, Kuo KC, Gehrke CW, Waalkes TP, Borek E.
    Clin Chem; 1977 Aug 28; 23(8):1427-35. PubMed ID: 872405
    [No Abstract] [Full Text] [Related]

  • 19. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle.
    Lehtiö H, Mäenpää PH.
    Clin Chim Acta; 1977 Oct 01; 80(1):181-5. PubMed ID: 908140
    [Abstract] [Full Text] [Related]

  • 20. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
    Kvist E, Sjølin KE.
    Scand J Urol Nephrol; 1990 Oct 01; 24(4):283-5. PubMed ID: 2274752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.